Tarsus Pharmaceuticals Inc (TARS)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -110.423 | -15.386 | -23.285 | -7.881 | -30.529 | -55.089 |
| Return on Equity (%) | 194.83 | 126.919 | -33.519 | -8.312 | -34.53 | -69.709 |
| Return on Invested Capital (%) | -122.265 | -14.426 | -24.183 | -7.364 | -33.268 | -65.602 |
| Operating Margin (%) | N/A | N/A | N/A | -24.15 | -232.011 | -759.712 |
| Net Profit Margin (%) | N/A | N/A | N/A | -24.246 | -240.514 | -778.89 |
| Book Value Per Share | 1.063 | 21.684 | 8.167 | 8.055 | 7.217 | 5.834 |
| Earnings Per Share | -0.634 | -1.764 | -1.319 | -0.668 | -2.323 | -4.105 |
| Cash Per Share | 1.133 | 21.893 | 8.273 | 8.277 | 2.681 | 6.795 |
| Working Capital Per Share | 1.06 | 21.614 | 8.132 | 7.946 | 7.855 | 6.621 |
| Operating Profit Per Share | N/A | N/A | N/A | 2.655 | 0.93 | 0.479 |
| EBIT Per Share | -0.634 | -1.764 | -1.319 | -0.665 | -2.323 | -4.105 |
| EBITDA Per Share | -0.634 | -1.764 | -1.319 | -0.665 | -2.323 | -4.105 |
| Free Cash Flow Per Share | -0.632 | -1.712 | -1.302 | -0.655 | -2.316 | -3.965 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 2.08M | 2.65M | 20.32M | 20.7M | 26.73M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | 26.73M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -909.4 | N/A | N/A | N/A | -125.835 | N/A | N/A |
| Net Profit Margin (%) | N/A | -936.76 | N/A | N/A | N/A | -129.395 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 1.79B |
| Price to Earnings Ratio | -13.09 |
| Price to Sales Ratio | 101.95 |
| Price to Cash Ratio | 7.91 |
| Price to Book Ratio | 9.03 |
| Dividend Yield | - |
| Shares Outstanding | 38.23M |
| Average Volume (1 week) | 898.03k |
| Average Volume (1 Month) | 752.01k |
| 52 Week Change | 109.46% |
| 52 Week High | 57.14 |
| 52 Week Low | 20.0818 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
